# OnCo record paper-hofmarcher-cee-cancer-medicine-access-esmo-open-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-hofmarcher-cee-cancer-medicine-access-esmo-open-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-hofmarcher-cee-cancer-medicine-access-esmo-open-2023" ;
  schema:name "Access to novel cancer medicines in four countries in Central and Eastern Europe in relation to clinical benefit"@en ;
  schema:description "Of 124 indications of cancer medicines authorised in the EU from 2011 to 2020, Hungary reimbursed 40%, and the median wait from authorisation to reimbursement was 37 months, the longest of the four countries studied."@en ;
  schema:url <https://onco.cc/key-papers/paper-hofmarcher-cee-cancer-medicine-access-esmo-open-2023/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.esmoop.2023.101593>, <https://pubmed.ncbi.nlm.nih.gov/37413761/> ;
  schema:sameAs <https://doi.org/10.1016/j.esmoop.2023.101593> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Hofmarcher T, Szilagyiova P, Gustafsson A, Dolezal T, Rutkowski P, Baxter C, Karamousouli E." ;
  onco:cancers <https://onco.cc/cancers/lung-cancer/>, <https://onco.cc/cancers/breast-cancer/> ;
  onco:institutions <https://onco.cc/institutions/neak-hungary/> .
